Twist Bioscience Corp
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Leproust Emily M. (Chief Executive Officer) sold 4,548 shares of Twist Bioscience Corp (TWST) at an average of $202.15 ($200.44–$207.46, $0.92M total) across 8 trades on 2026-10-05 under a Rule 10b5-1 trading plan.
Twist Bioscience (TWST) shares fell 16.1% to $171.96 after ARK Invest sold $18M worth of shares, marking 21 straight sessions of selling. Insiders also sold shares, and the stock is 42.9% above its fair value estimate. Analysts' average price target is $115.27, suggesting significant downside from the prior close of $205.
Twist Bioscience (TWST) stock rose 10.19% after announcing AI drug discovery deals with Eli Lilly's TuneLab. The company reported $118.4M in quarterly revenue, a $35.1M net loss, and positive operating cash flow of $1.1M. Analysts have raised price targets, with Guggenheim setting it at $212. TWST is seen as a key player in AI-driven biotech.
Over the past 7 days, AlphAI's AI scored 11 news stories mentioning TWST (Twist Bioscience Corp). Coverage has skewed bearish: 2 bullish, 5 neutral, and 4 bearish.
Recent TWST coverage spans insider activity, market movers and financial news.
In the last 30 days, TWST insiders filed 45 SEC Form 4 transactions — no purchases and 45 sales ($78.2M). The most active reporter was Leproust Emily M., Chief Executive Officer, with 35 filings. 73% of those filings were made under pre-arranged Rule 10b5-1 plans.
The insider sale may signal modest selling pressure on TWST.
The disclosed institutional and insider sell‑offs are driving a sharp sell‑off, suggesting continued downward pressure.
The Lilly partnership is expected to drive near‑term buying pressure.
The insider sale may create slight selling pressure on TWST.
Significant insider selling by senior officers may signal concerns about near‑term valuation.
AlphAI scores every news story that mentions TWST with an AI model for sentiment and relevance, and aggregates insider trades from Twist Bioscience Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Leproust Emily M. (Chief Executive Officer) sold 4,548 shares of Twist Bioscience Corp (TWST) at an average of $202.15 ($200.44–$207.46, $0.92M total) across 8 trades on 2026-10-05 under a Rule 10b5-1 trading plan.
1 min readTwist Bioscience (TWST) shares fell 16.1% to $171.96 after ARK Invest sold $18M worth of shares, marking 21 straight sessions of selling. Insiders also sold shares, and the stock is 42.9% above its fair value estimate. Analysts' average price target is $115.27, suggesting significant downside from the prior close of $205.
2 min readTwist Bioscience (TWST) stock rose 10.19% after announcing AI drug discovery deals with Eli Lilly's TuneLab. The company reported $118.4M in quarterly revenue, a $35.1M net loss, and positive operating cash flow of $1.1M. Analysts have raised price targets, with Guggenheim setting it at $212. TWST is seen as a key player in AI-driven biotech.
3 min readTwist Bioscience Corp. officer Emily M. Leproust proposed selling 4,548 common shares on October 5, 2026, valued at $919,373.72. She previously sold 356,546 shares on September 17, 2026, worth $56,330,878.38, according to a regulatory filing.
1 min readTwist Bioscience insiders sold shares totaling over $9.1M. Dennis Cho, Patrick Finn, Paula Green, and Adam Laponis sold shares at $188.884 each, with remaining holdings of 63,789, 185,088, 106,632, and 100,576 shares respectively.
1 min readLaponis Adam (Chief Financial Officer) sold 8,057 shares of Twist Bioscience Corp (TWST) at $188.88 ($1.52M total) on 2026-10-02.
1 min readGreen Paula (SVP of Human Resources) sold 10,088 shares of Twist Bioscience Corp (TWST) at $188.88 ($1.91M total) on 2026-10-02.
1 min readFinn Patrick John (President and COO) sold 25,714 shares of Twist Bioscience Corp (TWST) at $188.88 ($4.86M total) on 2026-10-02.
1 min readLeproust Emily M. (Chief Executive Officer) sold 46,391 shares of Twist Bioscience Corp (TWST) at an average of $189.04 ($188.88–$200.00, $8.77M total) across 2 trades over 2026-10-01 to 2026-10-02 under a Rule 10b5-1 trading plan.
1 min readCho Dennis (See Remarks) sold 9,514 shares of Twist Bioscience Corp (TWST) at $188.88 ($1.80M total) on 2026-10-02.
1 min read
